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Abstract Urinary tract infections (UTI) after pediatric
kidney transplantation (KTX) are an important clinical
problem and occur in 15–33% of patients. Febrile UTI,
whether occurring in the transplanted kidney or the native
kidney, should be differentiated from afebrile UTI. The
latter may cause significant morbidity and is usually
associated with acute graft dysfunction. Risk factors for
(febrile) UTI include anatomical, functional, and demo-
graphic factors as well as baseline immunosuppression and
foreign material, such as catheters and stents. Meticulous
surveillance, diagnosis, and treatment of UTI is important
to minimize acute morbidity and compromise of long-term
graft function. In febrile UTI, parenteral antibiotics are
usually indicated, although controlled data are not avail-
able. As most data concerning UTI have been accumulated
retrospectively, future prospective studies have to be
performed to clarify pathogenetic mechanisms and risk
factors, improve prophylaxis and treatment, and ultimately
optimize long-term renal graft survival.
Keywords Kidneytransplantation.Urinarytractinfection.
Transplant pyelonephritis.Immunosuppression.
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Introduction
Kidney transplantation (KTX) is now considered the
treatment of choice for end-stage renal disease (ESRD) in
children [1]. Patient survival is approaching 100%, and
graft survival has improved significantly in recent years,
mainly due to improved immunosuppressive strategies [2].
The main problem, however, chronic allograft nephropathy
(CAN),remainsunresolved.InCAN,specificimmunological
but also nonimmunological risk factors, such as hypertension
and urinary tract infections (UTI), seem to play a role [3, 4],
so that the ultimate solution to the problem will rely on
several approaches.
Febrile UTI play a crucial role in progression of chronic
kidney disease even before KTX and is often associated
with anatomical urogenital abnormalities. Also, after KTX,
UTI may lead to kidney damage, negatively affecting long-
term graft survival by scarring and interstitial injury [5–7],
although precise data for the pediatric population are scarce
[8–10]. UTI management in such patients undoubtedly is
more complex compared with UTI in otherwise healthy
children, so that extrapolation of data is not always possible.
Furthermore hardly any current diagnostic and/or treatment
practices in such patients are evidence-based.
The aim of this teaching article is to summarize the clinical
relevance and details of UTI after renal transplantation. Our
focusismainlyonfebrileUTI(fUTI),althoughafebrileUTIis
also discussed. We discuss specific pathogenetic risk factors
as well as options for treatment and prophylaxis of this
frequent complication after KTX.
Diagnosis of UTI after KTX
In general, UTI diagnosis in healthy children and those with
urinary tract malformations or after KTX should follow the
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plantation are more complex, as they are immunocompro-
mised, often have anatomical urinary tract abnormalities,
and maintenance of organ function is pivotal.
UTI diagnosis is confirmed with growth of 10
5 colonies of
bacteria in a collected sample. As in the case in healthy
children, the method of urine collection is important in
transplant recipients. Bagged specimens are unreliable due to
the high degree of contamination, and midstream and
catheterized urine samples are preferred in infants and older
children, depending on clinical status. Suprapubic tap remains
the most accurate method with the least contamination but is
not used much in clinical transplantation [11, 12]. It is the
only method that can exclude bacterial or fungal contamina-
tion with certainty, however. An alternative, though invasive
method, of obtaining bladder urine with minimal contami-
nation is by means of catheterization. Introduction of
infection is feasible by this method, trauma of the urethra
may occur, and psychological stress for patient (and doctor)
may be high. The method may be superior in the ill child,
however, when urinalysis is required quickly, especially
when bladder volume is low [11].
Urinary abnormalities in UTI include leukocyturia, hema-
turia, and positive leukocyte esterase, often identified by
dipstick testing. The presence of white blood cells (WBC) in
urine is not limited to UTI but may occur in other conditions,
such as acute rejection, BK nephropathy, and presence of
foreign material, such as a stent, in the urinary tract. Data on
the diagnostic impact of these tests in KTX are not available.
In fUTI after KTX (transplant pyelonephritis), elevation of
inflammatory markers are typical, such as leucocytosis,
erythrocyte sedimentation rate, and C-reactive protein (CRP).
These parameters are not specific for UTI, but they may be
important to distinguish between transplant pyelonephritis and
rejection episodes[13], as renal dysfunction is a typical feature
for both. They are also important in follow-up, as they are
tools for monitoring response to antibiotic treatment [14].
There are few data concerning the optimal diagnostic
imaging during fUTI after KTX. Ultrasound is a noninva-
sive tool and may demonstrate hydronephrosis or swelling
of the transplanted kidney. Perfusion deficits may be
visualized by color-Doppler ultrasound, especially in the
power mode (Fig. 1). Dimercaptosuccinate acid (DMSA)
scintigraphy is regarded as the gold standard in the
diagnosis of acute pyelonephritis as well as in the
documentation of residual scarring. This tool has been
employed only occasionally in UTI after renal transplanta-
tion (Fig. 2). Long-term data suggest that fUTI may lead to
focal defects on DMSA scanning [5, 15], but also other
events, such as vascular complications and renal biopsies,
may do so, which has to be considered in the interpretation
of this diagnostic tool [16]. However, at present, no clear
recommendations can be made as to the use of DMSA
scanning as a diagnostic tool in transplant pyelonephritis,
neither in the acute phase, nor in follow-up.
Classification of UTI after KTX
Most importantly, afebrile UTI must be distinguished from
fUTI. Afebrile UTI may also affect the native kidneys,
which is a diagnostic dilemma. Patients with afebrile UTI
after KTX may be symptomatic (dysuria, frequency, etc.) or
may be completely asymptomatic, raising the question of
whether treatment is indicated. Furthermore, UTI, both
febrile and afebrile, may show recurrences. It should be
noted that immunosuppression, especially with steroids,
might alter the temperature response to infections by
suppressing cytokine production.
Fig. 1 Longitudinal power Doppler ultrasonogram of a patient with
transplant pyelonephritis showing vascular hypoperfusion in the cortex
Fig. 2 99mTc DMSA scan of a patient with acute transplant
pyelonephritis showing an uptake defect in the lower pole (arrow)
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Fever and renal dysfunction are the typical features of
fUTI after KTX. In some patients, symptoms and signs
of urosepsis may develop. The acute deterioration of
renal function during UTI is a well-known feature [6,
17] which, together with the significant inflammatory
parenchymal response, emphasizes the potential risk of
tissue damage in the transplanted kidney in acute and
long-term follow-up, despite normalization of serum
creatinine values after UTI. Acute rejection episodes may
be triggered by fUTI [18], and development of an
intrarenal abscess in the graft following UTI has also been
described [19].
Prevalence
A high prevalence of fUTI in children after renal
transplantation has been demonstrated by several retro-
spective studies. They are not limited to the immediate
posttransplant period but also occur later, especially in
girls [14]. In pediatric studies, the prevalence ranged
between 15% and 33% [6, 9, 10, 17]. Higher prevalence of
up to 61% has been demonstrated in adults; however, in
some studies, entry criteriaw e r el e s ss t r i c t ,s u c ha s
inclusion of patients with (asymptomatic) afebrile bacter-
iuria [20, 21]. Recently, Pelle et al. demonstrated a
prevalence of UTI of 75.1%; 18.7% of these patients
developed transplant pyelonephritis [22]. Other studies
have found a higher frequency in children; for instance,
admissions for UTIs in pediatric patients after renal
transplants in the United States averaged nearly 150 per
1,000 patient years at risk, compared with 67 among
adults (editorial comment following [23]).
Epidemiology
Although Escherichia coli remained the most frequently
isolated microorganism, as in other studies [8, 24, 25], it
was isolated less frequently than in the general pediatric
population, where it is found in up to 80% of UTIs [26].
This may be due to the underlying immunosuppression and
colonization. Also, some patients receive antibiotic prophy-
laxis or treatment, which may have an impact on coloni-
zation. Surveillance urinary cultures may help, especially
for patients with recurrent UTI and those with abnormal
lower urinary tract and neurogenic bladder; not infrequent-
ly, bacteria with multiple antibiotic resistances, such as
Pseudomonas sp., can be detected. Table 1 demonstrates
epidemiology of fUTI in published series as well as in
control populations.
Risk factors
Several risk factors for UTI have been elucidated by studies
in adults and children. Knowledge of these risk factors is
one key for prevention.
1. Anatomical factors
Underlying urological abnormalities have to be
regarded as risk factors for UTI even before transplan-
tation, such as hydronephrosis, vesicoureteric reflux
(VUR), and/or neurogenic bladder, often in combina-
tion. Surgery of the urinary tract before listing for
transplantation is often necessary and should decrease
the risk of infections, although in our retrospective
study, operated children per se had more UTIs, possibly
because patients represent a specific population at risk,
even after surgery [14]. Patients with urinary tract
malformations compromise about a third of children
with end-stage renal failure and include heterogeneous
disorders such as posterior urethral valves, prune-belly
syndrome, spina bifida, or urogenital sinus abnormal-
ities, which may lead to lower urinary tract dysfunction
[27–30]. In our study, structural disorders and neuro-
genic bladder were present in 33% of all patients with
fUTI.
Especially structural abnormalities of the bladder
anatomy and neurogenic bladder have been regarded as
specific risk factor that needs to be distinguished from
behavioral voiding problems (voiding dysfunction).
Neurogenic bladder leads to a higher incidence of UTI,
with associated morbidity and poorer graft function [31].
The presence of focal scars was associated with either
raised intravesical pressures or recurrent UTIs [5].
Although no controlled data are available that bladder
augmentation procedures prevent or decrease the rate of
UTI after transplantation, it seems mandatory that
evaluation and treatment of neurogenic bladder is very
important and should be performed before renal trans-
plantation, requiring specific follow-up after KTX.
2. Functional factors
In addition to abnormal bladder anatomy and neuro-
genic bladder, voiding dysfunction is present in many
patients and may also increase the risk of UTI in
analogy to the nontransplant population [32]. On the
other hand, a recent retrospective study from Herthelius
et al. [33, 34] suggested no increased frequency of UTI
after KTX in children with bladder dysfunction.
However, the study did not analyze the effect of
interventions in the patients with voiding dysfunction.
3. Vesicoureteric reflux (VUR)
Among the anatomical factors, the pathogenetic role of
VUR has been discussed as an especially important risk
factor for UTI after renal transplantation. A clear dis-
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1132 Pediatr Nephrol (2009) 24:1129–1136tinction has to be made, however. First, VUR is present
in many patients as an underlying diagnosis, and UTI
could affect the native and the transplanted kidney (or
both). The differential diagnosis between these entities is
almost impossible without sophisticated imaging studies.
Someauthorsrecommendnativenephrectomyofkidneys
with VUR to decrease the risk of native-kidney UTI after
KTX [35]. However, no controlled studies are available.
Also, pretransplant antireflux surgery did not reduce the
risk for fUTI after KTX in a recent study of Basiri et al.,
who compared 12 children with VUR who underwent
reimplantation to 17 children with VUR who did not
[36]. The lack of difference may be due to dysfunctional
voiding that is also often present in children with VUR
and that may be an independent risk factor for UTI, of
both native and transplanted kidney.
Second, VUR into the transplanted kidney in a
previously normal urinary tract may develop secondary
to transplant surgery, thereby increasing the risk for
transplant pyelonephritis. Dunn et al. [10] found an
increased incidence of pyelonephritis in pediatric renal
transplant patients who had VUR. Ranchin et al. tested
55 of 84 transplanted children during a period of
5 years [9] and demonstrated a 58% prevalence of
VUR. The rate of UTI was 60% and was similar in
patients with or without VUR in the overall analysis.
However, after excluding UTI related to catheteriza-
tion, the rate of transplant pyelonephritis was higher in
patients with VUR (p<0.02). Whether strict antireflux
surgery can reduce the risk of fUTI after renal
transplantation has not been studied so far. Correction
of vesicoureteric reflux into the kidney graft has been
shown to reduce the incidence of UTI in a small series
but was associated with obstructive complications [17],
which may be high, especially in the cohort with
associated abnormal bladder anatomy.
4. Stents and other manipulations
Foreign material, such as stents, urinary catheters,
and suture material, can cause UTI, as it is frequently
colonized by bacteria (and fungi). In the study by
Kamath et al., the odds ratio for UTI for ureteric stents
was 4.6 [37]. Therefore, these devices should only be
used for a short time [20] or avoided if possible.
Manipulation with or insertion of such foreign material
should therefore be performed with caution and
possibly with antibiotic prophylaxis, especially in the
initial posttransplant period, when high-dose immuno-
suppression increases the risk even further.
5. Gender
The rate of UTI in adult females has been reported to
be twice as high as in male renal transplant recipients [8,
20, 38], and we were able to confirm this finding for
children in our retrospective multicenter analysis [14].
Anatomical reasons (e.g. shortness of urethra) may be
relevant in children and adults, and in female adoles-
cents, sexual activities have to be taken into account
(and asked about), as well as predisposing immunolog-
ical factors in females [39].
6. Immunosuppression
Immunosuppression has an impact on defense mech-
anisms so that a theoretical impact on the incidence of
UTI should be present. A recent study indicated an
increased risk for patients on a mycophenolic-based
regimen, with an odds ratio of 1.9 [37], but not for
other immunosuppressants, especially induction treat-
ment with anti-CD3. Therefore, patients on high-dose
immunosuppression should be regarded as at risk for
bacterial and viral infections, including UTI. An
accumulation of risk factors (e.g. unnecessary cathe-
terization or manipulation at the urinary tract, should be
avoided or at least limited. Future treatment studies
should, in detail, also look at the impact of specific
immunosuppressants on infection, including UTI.
In our opinion, it should be emphasized that a
combination of risk factors occurs in many patients and
that it is unlikely that a single factor is responsible for the
development of febrile or afebrile UTI.
Do urinary tract infections affect long-term outcome?
Several reports indicate that despite acute graft dysfunction
during fUTI, long-term renal function was not different
between patients with and without infection [14, 40, 41].
Other reports show a less optimistic picture in patients
with UTI, not only in adults [22], but especially in children
[9, 34], and even more for those with recurrent UTIs [34]. In
this respect, especially the retrospective cohort study of
Abbott et al. in nearly 29,000 adult renal transplant patients
of the United States Renal Data System (USRDS) database
is of interest, because late UTIs were independently
associated with the risk of subsequent graft loss and even
death [38]. It remains difficult, however, to properly assess
the risk in these uncontrolled and partially selective series,
especially in view of an imperfect endpoint (i.e. serum
creatinine). It is also of special note that also in asymptom-
atic (afebrile) UTI, serum creatinine increases have been
reported [24].
More studies into the pathophysiology of UTI after KTX
are necessary in this respect. Serotypes and adherence
factors of bacteria such as Escherichia coli may have a
strong impact on acute and long-term graft dysfunction, as
suggested by a recent study from Rice et al. [42]. The
intensive inflammatory response indicated by CRP or other
markers, such as procalcitonin response, may be related to the
Pediatr Nephrol (2009) 24:1129–1136 1133degree of tissue destruction leading to fibrosis [43]. The con-
current treatment with steroids with their anti-inflammatory
properties may possibly even be a protective factor [44]. All
these issues need to be addressed to clarify the issue of long-
term endangerment. Last but not least, long-term clinical
variables need to be defined and collected.
Treatment of UTI after renal transplantation
Aggressive and specific treatment of fUTI is mandatory. In
our opinion, in fUTI, parenteral antibiotics should be
preferred, at least initially, to achieve fast tissue saturation.
The optimal treatment duration has not been studied, but we
favor 14 days in transplant pyelonephritis. In accordance
with Benador et al., we sometimes continue with oral
treatment when the clinical situation has improved [45]. As
Enterococcus and Pseudomonas spp. are more frequent, we
currently use a combination of ceftazidime and ampicillin
to cover for E. coli, Pseudomonas, and Enterococcus.
Others have recommended ampicillin and gentamicin for
t h es a m er e a s o n[ 46]. However, nephrotoxicity of the
latter is a concern. Oral fluoroquinolone medications such
as ciprofloxacin is another alternative in this situation.
Fungal UTIs may occur and require specific treatment;
in our center, antifungal prophylaxis is given during high-
dose antibiotic treatment. Treatment recommendation
for other centers may be different, however. Monitoring
of blood levels is important during acute UTI, as antibi-
otic treatment may interfere with resorption. Steroid dose
must be increased sometimes during fUTI, especially early
after renal transplantation, to avoid symptoms of adrenal
insufficiency.
Symptomatic afebrile UTI may be treated with oral
antibiotics unless specific risk factors are present (renal
dysfunction etc.) [11]. Again, treatment should be specific
and oral cephalosporin may be the first choice, especially if
the patient was on antibiotic prophylaxis. Whether asymp-
tomatic UTIs have to be treated remains controversial and
is often an individual decision. In patients with abnormal
bladder anatomy and catheterization, such as in spina bifida,
colonization is frequent, and symptoms such as dysuria may
be absent. There is no evidence and no consensus as to
whether in these patients bacterial colonization needs
treatment, including bladder washing with antibiotics. In
our centers, we currently only treat symptomatic patients
with abnormal bladder anatomy and bacterial colonization
and do not use antibiotic bladder irrigation.
Practical consequences for the clinician
Although UTIs cannot be prevented completely, preventa-
tive measures may be able to reduce the incidence and lead
to earlier and more effective treatment. Recurrences of fUTI
should be prevented, if at all possible.
1. Antibiotic prophylaxis
There are no systematic studies relating to use of
prophylactic antibiotics after renal transplantation. They
may be useful in the view of the high prevalence of UTI,
however, and most pediatric transplant centers prescribe
prophylactic antibiotics for the first 3–6 months post-
transplantation, or longer in refluxive patients [31, 41],
but sometimes also for Pneumocystis carinii prophy-
laxis. However, not all studies confirmed a beneficial
effect and even demonstrated a high bacterial resistance
rate [24]. If prophylactic antibiotics are used, it seems
that they should be administered for prolonged periods,
as fUTI may occur late, especially in girls.
2. Bladder dysfunction
As bladder dysfunction contributes to the risk of UTI,
exact diagnosis (and treatment) before transplantation
and surveillance is important. Simple methodology
(micturition protocols, uroflowmetry, and bladder ultra-
sound) for this evaluation exists and needs to be used.
Sometime, however, it is not possible to evaluate bladder
function before transplantation, e.g. in the anuric patient
who never had a voiding history. Patients with structural
and functional bladder abnormalities require regular
urodynamic monitoring and treatment: pharmacologic,
behavioral, or surgical. This includes frequent voiding,
treatment of constipation, and sometimes intermittent
catheterization. Correction of structural anomalies and
optimization of storage and emptying functions of the
bladder is recommended before transplantation. How-
ever, an abnormal urinary bladder is no longer a
contraindication to renal transplantation [21, 28, 31].
3. Miscellaneous
Other measures include high oral fluid intake and
hygienic measures, especially in the adolescent, sexually
active patients. Sometimes, home testing of urine by the
parent or patient with dipsticks is helpful to detect UTI
early. No data are available for alternative methods, such
as cranberry juice, urine acidification, etc.
Summary and conclusion
Children after renal transplantation are at high risk for
UTIs. Although anatomical factors including neurogenic
bladder increase the risk for UTI, the high prevalence in
girls and in patients with nonanatomical underlying
disorders indicate that further risk factors are present. The
severe renal dysfunction during fUTI and inflammatory
response indicates that fUTI has to be regarded as a serious
complication, endangering long-term graft survival. There-
1134 Pediatr Nephrol (2009) 24:1129–1136fore, prophylactic measures including antibiotic prophylaxis
andbladdertrainingshouldbeconsidered.Prospectivestudies
are urgently needed to evaluate precise mechanisms and the
value of preventive measures of this important complication.
Questions
(Answers appear following the reference list)
Which answer is true: UTIs after KTX
1. Pseudomonas and Enterococcus spp. cause UTIs after
renal transplantation:
a. In the same frequency as in unimmunocompro-
mised patients
b. More frequently than in immunologically healthy
children
c. Less frequently than in immunologically healthy
children
d. Are specifically related to graft rejection episodes
e. None of the above is true
2. Which answer is not true: diagnostic workup of a
patient after renal transplantation with fever typically
includes:
a. Renal biopsy
b. Renal ultrasound, including Doppler ultrasonography
c. Urine culture
d. Laboratory testing, including full blood count,
serum creatinine and CRP
e. Clinical examination
3. Long-termcomplicationsafterfUTI inpatientsafterKTX:
a. Are irrelevant
b. Develop only in patients with acquired diseases
c. Have been documented and include accelerated
graft loss and chronic allograft nephropathy
d. Are only present in females
e. Can be prevented by specific immunosuppression
4. Which answer is not true: the main differential
diagnosis of a patient with kidney graft dysfunction
and fever includes:
a. Cytomegalovirus infection
b. Acute rejection
c. Transplant pyelonephritis
d. Dehydration during viral illness
e. Malnutrition
5. Risk factors for UTI after KTX include:
a. Underlying urinary tract pathology
b. Female gender
c. VUR into kidney transplant
d. Voiding dysfunction and constipation
e. All of the above
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